MX2007005428A - Combinaciones de agonistas del receptor nicotinico alfa 7 y de la acetilcolina. - Google Patents

Combinaciones de agonistas del receptor nicotinico alfa 7 y de la acetilcolina.

Info

Publication number
MX2007005428A
MX2007005428A MX2007005428A MX2007005428A MX2007005428A MX 2007005428 A MX2007005428 A MX 2007005428A MX 2007005428 A MX2007005428 A MX 2007005428A MX 2007005428 A MX2007005428 A MX 2007005428A MX 2007005428 A MX2007005428 A MX 2007005428A
Authority
MX
Mexico
Prior art keywords
combinations
nicotinic acetylcholine
receptor agonists
acetylcholine alpha
alpha
Prior art date
Application number
MX2007005428A
Other languages
English (en)
Inventor
Graeme Bilbe
Conrad Gentsch
Annick Vassout
Joachim Nozulak
Dominik Feuerbach
Konstanze Hurth
Hans O Kalkman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2007005428A publication Critical patent/MX2007005428A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a combinaciones que comprenden cuando menos un agonista del receptor nicotinico alfa 7 de la acetilcolina y cuando menos un compuesto que se selecciona del grupo que consiste de (a) antipsicoticos convencionales, (b) antipsicoticos atipicos, (c) mejoradores de la capacidad cognitiva, de la atencion y/o de la memoria y (d) antidepresivos, y al uso de dichas combinaciones en el tratamiento de trastornos psiquiatricos.
MX2007005428A 2004-11-05 2005-11-03 Combinaciones de agonistas del receptor nicotinico alfa 7 y de la acetilcolina. MX2007005428A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424564A GB0424564D0 (en) 2004-11-05 2004-11-05 Organic compounds
PCT/EP2005/011787 WO2006048294A1 (en) 2004-11-05 2005-11-03 Combinations of nicotinic acetylcholine alpha 7 receptor agonists

Publications (1)

Publication Number Publication Date
MX2007005428A true MX2007005428A (es) 2007-05-18

Family

ID=33523294

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005428A MX2007005428A (es) 2004-11-05 2005-11-03 Combinaciones de agonistas del receptor nicotinico alfa 7 y de la acetilcolina.

Country Status (12)

Country Link
US (2) US20080306081A1 (es)
EP (3) EP2135609A1 (es)
JP (3) JP2008518896A (es)
KR (2) KR20130024974A (es)
CN (1) CN101039670A (es)
AU (1) AU2005300691A1 (es)
BR (1) BRPI0517647A (es)
CA (1) CA2582436C (es)
GB (1) GB0424564D0 (es)
MX (1) MX2007005428A (es)
RU (1) RU2007120690A (es)
WO (1) WO2006048294A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
US20060211686A1 (en) * 2005-03-18 2006-09-21 Abbott Laboratories Alpha7 Neuronal nicotinic receptor ligand and antipsychotic compositions
EP2258358A3 (en) * 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
MX2010009290A (es) * 2008-02-29 2010-09-14 Biolab Sanus Farmaceutica Ltda Composicion farmaceutica.
JO3250B1 (ar) * 2009-09-22 2018-09-16 Novartis Ag إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
CN103260619A (zh) * 2010-07-26 2013-08-21 英维沃医药有限公司 利用某些α-7烟酸受体激动剂与乙酰胆碱酯酶抑制剂的组合治疗认知障碍
ES2716865T3 (es) * 2011-02-18 2019-06-17 Scripps Research Inst Diferenciación dirigida de células precursoras de oligodendrocitos a un destino celular mielinizante
WO2012127393A1 (en) * 2011-03-18 2012-09-27 Novartis Ag COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE
AU2021387993A1 (en) * 2020-11-25 2023-06-08 Vanda Pharmaceuticals Inc. Treatment of public speaking anxiety with an alpha-7 nicotinic acetylcholine receptor agonist

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB261309A (en) 1926-07-23 1926-11-18 Oswald Pfeiffer Improvements in collapsible grids
GB281309A (en) 1926-11-27 1928-03-29 Inventia Patent Verwert Ges Improvements in or relating to brushing machines having replaceable brush members
US3310553A (en) 1962-09-25 1967-03-21 Pfizer & Co C Alkylated thioxathenesulfonamides
US3539573A (en) 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
GB0010955D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
PE20021019A1 (es) * 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
AR036040A1 (es) * 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
MXPA04000779A (es) * 2001-08-24 2004-04-20 Pharmacia & Up John Company 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades.
JP2005511613A (ja) * 2001-11-08 2005-04-28 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー 疾患治療用アザビシクロ置換ヘテロアリール化合物
EP1542999A1 (en) * 2002-08-01 2005-06-22 Pharmacia & Upjohn Company LLC 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
ATE384720T1 (de) 2002-08-14 2008-02-15 Neurosearch As Chinucledin - derivate und deren verwendung
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
AU2003284898A1 (en) * 2002-10-29 2004-05-25 Micro, Inc. Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer's disease
EA200500783A1 (ru) * 2002-12-11 2005-12-29 ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи Комбинация для лечения синдрома дефицита внимания с гиперактивностью
FR2931677B1 (fr) * 2008-06-02 2010-08-20 Sanofi Aventis Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs
WO2010022556A1 (zh) 2008-08-27 2010-03-04 中兴通讯股份有限公司 一种下行信号的分扇区处理方法及基站
US10066977B2 (en) 2009-01-26 2018-09-04 Canon U.S. Life Sciences, Inc. Microfluidic flow monitoring

Also Published As

Publication number Publication date
CA2582436C (en) 2016-10-04
JP2008518896A (ja) 2008-06-05
EP1809285A1 (en) 2007-07-25
EP2332537A1 (en) 2011-06-15
EP2135609A1 (en) 2009-12-23
GB0424564D0 (en) 2004-12-08
JP2014196328A (ja) 2014-10-16
BRPI0517647A (pt) 2008-10-14
KR20130024974A (ko) 2013-03-08
KR101302898B1 (ko) 2013-09-06
RU2007120690A (ru) 2008-12-10
CN101039670A (zh) 2007-09-19
KR20070073881A (ko) 2007-07-10
US20100125063A1 (en) 2010-05-20
US20080306081A1 (en) 2008-12-11
WO2006048294A1 (en) 2006-05-11
JP2012255039A (ja) 2012-12-27
CA2582436A1 (en) 2006-05-11
AU2005300691A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
MX2007005428A (es) Combinaciones de agonistas del receptor nicotinico alfa 7 y de la acetilcolina.
NO20081016L (no) Nye 1-aryl-3-azabicyklo(3.1.0)heksaner, fremstilling og bruk for å behandle nevropsykiatriske lidelser
ATE435206T1 (de) Heteroarylsulfonylstilbene als 5-ht2a- antagonisten
CL2007001734A1 (es) Compuestos derivados de imidazol condensados con heterociclos nitrogenados; composicion farmaceutica; y uso para tratar o prevenir la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras.
DE69929235D1 (de) Spiro-indole als y5-rezeptor antagonisten
WO2005074598A3 (en) Nitroxyl progenitor compounds and methods of use
RS51106B (sr) Derivati prolina i njihova upotreba kao inhibitora dipeptidil peptidaze iv
NO20091734L (no) Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse
ZA200502247B (en) Selected CGRP antagonists, method for production and use thereof as medicament.
NO20013444D0 (no) Triazolforbindelser med dopamin-D3-reseptor-affinet
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
EP1199069A3 (en) Use of an estrogen agonist/antagonist for assessing, improving, or maintaining urogenital health
CL2006003736A1 (es) Compuestos derivados de triazina o pirimidina sustituida, antagonistas del receptor de prokineticina 1, composicion farmaceutica; y uso en el tratamiento de trastornos gastrointestinales.
FR2913358B1 (fr) Dispositif d'allumage d'une composition aluminothermique, creuset l'incorporant et procedes associes.
WO2005112903A3 (en) Use of ghrelin antagonists for improving cognition and memory
DE602005009977D1 (de) Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
AU2003274307A1 (en) 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist
TW200519109A (en) Muscarinic acetylcholine receptor antagonists
NL1025710A1 (nl) Azabicyclische pyridyloxymethyl- en benzisoxazoolderivaten.
MXPA06000663A (es) Antagonistas del receptor muscarinico de acetilcolina.
IL182738A0 (en) Enantiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors
TW200716130A (en) Purified form of tanaproget
EA200500544A1 (ru) Игровой аппарат
CA2505990A1 (en) Palonosetron for the treatment of chemotherapy-induced emesis
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.

Legal Events

Date Code Title Description
FG Grant or registration